Which class of medication performs better for treating anxiety or OCD in children and adolescents, SSRI’s or SNRI’s? This study sorts through the comparative efficacy vs. side effects so that you can better decide how to help your patients.

We all need more resources to offer parents to help them with challenging behaviors. Online applications are springing up to address all sorts of difficulties. This study reports on a promising online program to teach parents how to manage tantrums in children.

We all need to become more aware of the differences in the population prevalence of mental health problems among various communities. This research update offers more recent data, upending what we knew when DSM-5 came out, and giving us a better sense of how to assess black youth and avoiding bias in the diagnostic process.

By successfully completing the test you will be awarded a certificate for 2 CME credits.

After reading these articles, you should be able to…

At Carlat we dig deeper: Last fall it was the possibility of suicidality with antidepressants when we see the real data; this winter, it was the lack of clinical relevance of CYP enzyme testing when we use medications carefully; and this spring, beneath the apparent weight of thousands of studies that turn out to be flawed, we found an absence of a definable effect size for the massive $17 billion applied behavioral analysis industry.

Thousands of studies that carry the weight of support for Applied Behavioral Analysis treatment for autism are flawed. See what we learned about effect sizes for this massive 17-billion-dollar industry and learn about why it is so hard to study more functional but meaningful change vs rote but less useful learning.

Clinicians need to efficiently respond to patient requests for records and document their considered judgment in decisions about restricting records to patients and families.

As of April, 2021, we have a brand new non-stimulant medication approved for treatment of ADHD in the US. Are we excited? Does this represent an advance over other efforts to produce effective non-stimulant medications for ADHD, or is it another instance of ‘me too’? What does the supporting research tell us? And what side effects do we need to watch out for? Read and learn.